Mariella Chiricolo Selected Research

beta-D-Galactoside alpha 2-6-Sialyltransferase

2/2006	Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948.
1/2006	Beta-galactoside alpha2,6-sialyltransferase and the sialyl alpha2,6-galactosyl-linkage in tissues and cell lines.
1/2004	Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mariella Chiricolo Research Topics

Disease

13	Neoplasms (Cancer) 01/2019 - 01/2004
7	Colonic Neoplasms (Colon Cancer) 01/2019 - 11/2003
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 07/2007
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 02/2009
3	Neoplasm Metastasis (Metastasis) 08/2014 - 01/2011
2	Wounds and Injuries (Trauma) 01/2019 - 02/2006
1	Microsatellite Instability 01/2019
1	Disease Progression 01/2019
1	Non-Muscle Invasive Bladder Neoplasms 01/2018
1	Genomic Instability 08/2017
1	Inflammation (Inflammations) 02/2016
1	Hemorrhage 01/2014
1	Fibrosis (Cirrhosis) 01/2004
1	Liver Diseases (Liver Disease) 01/2004
1	Carcinoma (Carcinomatosis) 11/2003

Drug/Important Bio-Agent (IBA)

6	Messenger RNA (mRNA)IBA 01/2019 - 11/2003
6	AntigensIBA 08/2017 - 07/2007
5	Glycoproteins (Glycoprotein)IBA 02/2018 - 01/2004
5	Complementary DNA (cDNA)IBA 01/2018 - 11/2003
4	SialyltransferasesIBA 01/2019 - 09/2014
3	LigandsIBA 02/2018 - 01/2011
3	CarbohydratesIBA 01/2018 - 01/2012
3	SugarsIBA 08/2017 - 01/2006
3	Lewis Blood Group AntigensIBA 09/2014 - 01/2012
3	lactosamineIBA 09/2014 - 01/2004
3	Protein Isoforms (Isoforms)IBA 08/2014 - 01/2006
3	Sialyl Lewis X AntigenIBA 08/2014 - 07/2007
3	beta-D-Galactoside alpha 2-6-SialyltransferaseIBA 02/2006 - 01/2004
2	GlycosyltransferasesIBA 01/2019 - 09/2014
2	GangliosidesIBA 09/2014 - 01/2012
2	SelectinsIBA 08/2014 - 01/2011
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2013 - 02/2006
2	FucosyltransferasesIBA 01/2011 - 07/2007
2	LectinsIBA 02/2009 - 01/2006
2	EnzymesIBA 02/2006 - 01/2006
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	AgarIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	matrigelIBA 01/2019
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2018
1	DisaccharidesIBA 01/2018
1	Oxidants (Oxidizing Agents)IBA 08/2017
1	Interleukin-6 (Interleukin 6)IBA 08/2017
1	AcetylglucosamineIBA 02/2016
1	polysialic acidIBA 09/2014
1	Sialic AcidsIBA 09/2014
1	von Willebrand FactorIBA 01/2014
1	VitronectinIBA 04/2013
1	3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferaseIBA 01/2011
1	Small Interfering RNA (siRNA)IBA 01/2011
1	beta-1,4-N-acetyl-galactosaminyl transferase 2IBA 07/2007
1	Fibronectins (Fibronectin)IBA 02/2006
1	Neuraminidase (Sialidase)IBA 02/2006
1	IntegrinsIBA 02/2006
1	CollagenIBA 02/2006
1	DNA PrimersIBA 01/2006
1	GlycoconjugatesIBA 01/2004
1	FetuinsIBA 11/2003

Therapy/Procedure

2	Therapeutics 01/2019 - 08/2017
1	Immunotherapy 01/2018
1	Investigational Therapies (Experimental Therapy) 09/2014